Abstract:OBJECTIVE:To develop a new kind of vector system called gene-viral vector, which combines the advantages of gene and virus therapies.METHODS:Using recombinant technology, an anti-tumor gene was inserted into the genome of replicative virus specific for tumor cells. The cell killing effect, reporter gene expression of the green fluorescence protein, anti-tumor gene expression of mouse interleukin-12 (mIL-12) and replication of virus were observed by the methods of cell pathology, fluorescence microscopy, ELISA and electron microscopy, respectively.RESULTS:A new kind of gene-viral vector system of adenovirus, in which the E1b-55 kD gene was deleted but the E1a gene was preserved, was constructed. The vector system, like the replicative virus ONYX-015, replicated and proliferated in tumor cells but not in normal ones. Our vector had an advantage over ONYX-015 in that it carried different kinds of anti-tumor genes to enhance its therapeutic effect. The reporter gene expression of the green fluorescence protein in tumor cells was much better than the adenovirus vector employed in conventional gene the rapy, and the expression in our vector system was as low as or even less than that in the conventional adenovirus gene therapy system. Similar results were observed in experiments with this vector system carrying the anti-tumor gene mIL-12. Replication and proliferation of the virus carrying the mIL-12 gene in tumor cells were confirmed by electron microscopy.CONCLUSIONS:Gene-viral vectors are new vectors with an anti-tumor gene inserted into the genome of replicative virus specific for tumor cells. Because of the specific replication and proliferation of the virus in tumor cells, expression of the anti-tumor gene is increased hundreds to thousands of times. This approach takes full advantages of gene therapy and virus therapy to enhance the effect on the tumor. It overcomes the disadvantages of conventional gene therapy, such as low transfer rate, low gene expression, lack of target tropism, and low anti-tumor activity. We believe that this is a promising means for future tumor treatment.

Construction of a Novel Gene Therapy Lentiviral Vector for Drug Resistant Selection and Detection in Vivo

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

A novel inducible lentiviral system for multi-gene expression with human HSP70 promoter and tetracycline-induced promoter

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Lentiviral Delivery of Proteins for Genome Engineering

Development of a Novel Bivalent Baculovirus Vectors for Complement Resistance and Sustained Transgene Expression and Its Application in Anti-Angiogenesis Gene Therapy.

Constructing a Lentiviral Vector Overexpressing Indoleamine 2,3-Dioxygenase

Construction of a Lentivirus Vector Expressing Three Reporter Genes and Its Experimental Study

Broadening The Versatility Of Lentiviral Vectors As A Tool In Nucleic Acid Research Via Genetic Code Expansion

Gene-viral Vectors: a Promising Way to Target Tumor Cells and Express Anticancer Genes Simultaneously.

Analysis of hepatic lentiviral vector transduction; implications on preclinical studies and clinical gene therapy protocols.

Construction and Verification of Novel Lentiviral Expression Vector Plox-Cmv-e/p Based on Cre-LoxP System

Construction of novel conditional transgenic vectors for molecular therapy based on the Tet-On system and flanked with insulators in a single plasmid

Integrase-deficient lentivirus: opportunities and challenges for human gene therapy.

Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols

[Construction and Expression Analysis of Micro-Linear Vector As a New General Gene Therapy Vector].

A Self-Deletion Lentiviral Vector to Reduce the Risk of Replication-Competent Virus Formation

Progression and Application of HIV-1-derived Lentivectors

Construction of lentiviral expression vector with telomerase reverse transcriptase and green fluorescent protein recombinant gene

Construction and Identification of Lentiviral Vector-mediated RNA Interference of VEGF Gene